1. Avner, P. R., Dove, W. F., Dubois, P., Gaillard, J. A., Guenet, J.-L., Jacob, F., Jakob, H., and Shedlovsky, A.: The genetics of teratocarcinoma transplantation: Tumor formation in allogeneic hosts by the embryonal carcinoma cell lines F9 and PCC3. Immunogenetics 7: 103?115, 1978
2. Bishop, G. A. and Dove, W. F.: Semisyngeneic hybrid resistance to murine teratocarcinoma cells. Immunogenetics 10: 383?393, 1980
3. Boon, T., Van Pel, A., and Warmer, G.: Mouse teratocarcinoma cell variants obtained by mutagenesis: rejection by syngeneic mice and immunization against the original tumor cell line. In H. Peters (ed.): Protides of Biological Fluids. 27th Colloquium 1979. Pergamon Press, Oxford and New York, 1979
4. Dobrovolskaia-Zavadskaia, N.: Sur la mortification spontanee de la queue chez la souris nouveau-nee et sur l'existance d'un caractere (facteur) hereditaire ?non viable?. C. R. Soc. Biol. 97: 114?116, 1927
5. Erickson, R. P. and Lewis, S. E.: Cell surfaces and embryos: Expression of the F9 teratocarcinoma antigen in T-region lethal, other lethal, and normal pre-implantation mouse embryos. J. Reprod. Immunol. 2: 293?304, 1980